IL-1β and TGF-β1 have been shown to be involved in the pathology of fibrosis67, an integral feature of IgG4-related disease, thus further strengthening the putative role of CD4-positive CTLs. Here, CD4 is linked to immunoglobulin G4-related sclerosing disease.